{
"@context": "https://schema.org",
"@type": "Article",
"headline": "UK government sets out 2026 branded medicines Statutory Scheme repayment rate",
"url": "https://www.lexblog.com/2026/02/12/uk-government-sets-out-2026-branded-medicines-statutory-scheme-repayment-rate/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-R290EW02",
"url": "https://www.lexblog.com/lib/R290EW02/"
},
"datePublished": "2026-02-12T05:45:11-05:00",
"dateModified": "2026-02-12T05:45:30-05:00",
"author": {
"@type": "Person",
"name": "Adela Williams, Christopher Bates"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Arnold & Porter Kaye Scholer LLP"
},
"organizationScope": "at-publication",
"isPartOf": "BioSlice Blog",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.biosliceblog.com/?p=3943",
"sourceStability": "may-move"
}